Home › Compare › BCTXW vs FCPT

BCTXW vs FCPT: Dividend Comparison 2026

BCTXW yields 222222.22% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BCTXW wins by $1.4076449094288678e+30M in total portfolio value
10 years
BCTXW
BCTXW
● Live price
222222.22%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4076449094288678e+30M
Annual income
$1,406,399,938,745,922,600,000,000,000,000,000,000.00
Full BCTXW calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — BCTXW vs FCPT

📍 BCTXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBCTXWFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BCTXW + FCPT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BCTXW pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BCTXW
Annual income on $10K today (after 15% tax)
$18,888,889.10/yr
After 10yr DRIP, annual income (after tax)
$1,195,439,947,934,034,100,000,000,000,000,000,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, BCTXW beats the other by $1,195,439,947,934,034,100,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BCTXW + FCPT for your $10,000?

BCTXW: 50%FCPT: 50%
100% FCPT50/50100% BCTXW
Portfolio after 10yr
$7.038224547144339e+29M
Annual income
$703,199,969,372,961,300,000,000,000,000,000,000.00/yr
Blended yield
99.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

BCTXW
No analyst data
Altman Z
-3.9
Piotroski
2/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BCTXW buys
0
FCPT buys
0
No recent congressional trades found for BCTXW or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBCTXWFCPT
Forward yield222222.22% ✓6.05%
Annual dividend / share$2.00 ✓$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$1.4076449094288678e+30M$49.1K ✓
Annual income after 10y$1,406,399,938,745,922,600,000,000,000,000,000,000.00 ✓$5,775.28
Total dividends collected$1.4075633997820162e+30M$24.1K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BCTXW vs FCPT ($10,000, DRIP)

YearBCTXW PortfolioBCTXW Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$22,232,922$22,222,222.47$11,401$700.92+$22.22M → BCTXW
2$46,198,083,549$46,174,294,322.26$13,064$864.84+$46198.07M → BCTXW
3$89,718,755,932,306$89,669,323,982,908.17$15,051$1,072.48+$89718755.92M → BCTXW
4$162,845,400,843,462,850$162,749,401,774,615,260.00$17,442$1,337.22+$162845400843.45M → BCTXW
5$276,249,751,218,492,180,000$276,075,506,639,589,670,000.00$20,340$1,677.08+$276249751218492.16M → BCTXW
6$437,989,491,440,595,100,000,000$437,693,904,206,791,440,000,000.00$23,880$2,116.57+$437989491440595136.00M → BCTXW
7$649,026,193,150,457,500,000,000,000$648,557,544,394,616,000,000,000,000.00$28,241$2,689.36+$649026193150457544704.00M → BCTXW
8$898,874,233,030,415,400,000,000,000,000$898,179,775,003,744,500,000,000,000,000.00$33,660$3,442.07+$8.988742330304155e+23M → BCTXW
9$1,163,524,002,752,517,800,000,000,000,000,000$1,162,562,207,323,175,100,000,000,000,000,000.00$40,456$4,439.95+$1.1635240027525178e+27M → BCTXW
10$1,407,644,909,428,867,700,000,000,000,000,000,000$1,406,399,938,745,922,600,000,000,000,000,000,000.00$49,063$5,775.28+$1.4076449094288678e+30M → BCTXW

BCTXW vs FCPT: Complete Analysis 2026

BCTXW — Stock

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Full BCTXW Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this BCTXW vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BCTXW vs SCHDBCTXW vs JEPIBCTXW vs OBCTXW vs KOBCTXW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.